SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (676)2/17/1998 1:20:00 PM
From: David Cathcart   of 1826
 
Peter,

It is nice to see confirmation of the news that was expected. Now we will finally see how big the Sjogren's market is, but it will take time. Since they will not begin to actively promote Salagen for Sjogren's until April 1st, there will be no significant positive impact on the present quarter. In fact, we have to expect ramp up costs to effect the bottom line for this quarter.

Blitzer has repeatedly said that their sales force, presently at 22 and soon-to-be 24 strong, is one of their greatest assets. I have no idea whether this is a sufficient size to address the newly enlarged Salagen market. Can anyone help?

I remain disappointed in the lack of a MGI Pharma web-site. These things are cheep to do and now practically any kid out of college can create one. With the new approval, the potential would exist for links to the two Sjogren's web-sites mentioned in the news release. This would be an extremely cost effective way to reach the end consumer and create product awareness.

Bottom line, this is great news. For me, it's one down and two to go (phase II and the European deal). To borrow and paraphrase a line from RDB, with this new approval, it is easier than ever to drool over the idea of shrinking tumors.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News